Inari Medical Inc
(NAS:NARI)
$
51.92
0.89 (1.74%)
Market Cap: 3.04 Bil
Enterprise Value: 2.96 Bil
PE Ratio: 0
PB Ratio: 6.98
GF Score: 80/100 Inari Medical Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023 / 02:40PM GMT
Release Date Price:
$67.59
(+2.52%)
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate
Perfect. Thank you, everyone. I'm Kallum Titchmarsh, medical device analyst here at Morgan Stanley. Delighted today to be joined with the Inari Medical team. We've got Drew Hykes, CEO; Mitch Hill, CFO; and Tom Tu, CMO. Gents, thank you so much for joining.
Before I get started, I need to read you the research disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
Kallum L Titchmarsh;Andrew J. Hykes
Morgan Stanley, Research Division - Research Associate;Inari Medical, Inc. - CEO, President
So just wanted to start, Drew, curious to hear what's occupying your time now, 9 months as CEO. How has that changed from the start to where we're at this point?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot